Matthew Odenwald, MD, PhD, is an expert hepatologist who specializes in diagnosing and treating the full spectrum of liver diseases. Dr. Odenwald provides personalized care for patients with conditions such as hepatitis, fatty liver disease, liver cancer and cirrhosis. He also cares for patients before and after receiving liver transplants.
With his expertise in liver diseases, Dr. Odenwald is committed to offering his patients comprehensive care, including managing symptoms, slowing disease progression and preventing complications. His goal is to tailor treatment plans to each individual patient in order to address their unique needs and circumstances.
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality.
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality. Sci Adv. 2025 Jun 06; 11(23):eadt1466.
PMID: 40465720
Author Correction: Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration.
Author Correction: Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2025 Jun; 10(6):1550.
PMID: 40379934
Successful Treatment of Refractory Chylous Ascites With Octreotide in a Patient With Decompensated Cirrhosis.
Successful Treatment of Refractory Chylous Ascites With Octreotide in a Patient With Decompensated Cirrhosis. ACG Case Rep J. 2024 Apr; 11(4):e01322.
PMID: 38560017
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration.
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2024 Jan; 9(1):55-69.
PMID: 38177297
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection.
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
PMID: 38103544
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease.
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
PMID: 37845315
Evolving challenges with long-term care of liver transplant recipients.
Evolving challenges with long-term care of liver transplant recipients. Clin Transplant. 2023 10; 37(10):e15085.
PMID: 37545440
Reduced immunomodulatory metabolite concentrations in peri-transplant fecal samples from heart allograft recipients.
Reduced immunomodulatory metabolite concentrations in peri-transplant fecal samples from heart allograft recipients. Front Transplant. 2023; 2:1182534.
PMID: 38993864
Recurrent NAFLD post-LT: Sisyphus' boulder or Proteus' parable?
Recurrent NAFLD post-LT: Sisyphus' boulder or Proteus' parable? Liver Transpl. 2023 09 01; 29(9):917-918.
PMID: 37071070
PRO: Coronavirus disease 2019 vaccination should be mandatory for liver transplant candidates.
PRO: Coronavirus disease 2019 vaccination should be mandatory for liver transplant candidates. Clin Liver Dis (Hoboken). 2022 Nov; 20(5):151-153.
PMID: 36447910